AR040279A2 - COMPOSITIONS CONTAINING SERTRALINE SALT - Google Patents

COMPOSITIONS CONTAINING SERTRALINE SALT

Info

Publication number
AR040279A2
AR040279A2 ARP030102179A ARP030102179A AR040279A2 AR 040279 A2 AR040279 A2 AR 040279A2 AR P030102179 A ARP030102179 A AR P030102179A AR P030102179 A ARP030102179 A AR P030102179A AR 040279 A2 AR040279 A2 AR 040279A2
Authority
AR
Argentina
Prior art keywords
compositions containing
sertraline salt
containing sertraline
cmax
solubilizing agent
Prior art date
Application number
ARP030102179A
Other languages
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR040279(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR040279A2 publication Critical patent/AR040279A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Composición que contiene una forma de sal de sertralina altamente soluble que tiene una solubilidad mayor a 10mg/ml en agua pura y una cantidad de agente solublilizante suficiente para producir in vivo una Cmax y/o una AUC que es mayor en al menos un 10 % que la Cmax y/o la AUC producida por una composición comparativa de materia idéntica a la anterior pero sin incluir el mencionado agente solubilizante.Composition containing a form of highly soluble sertraline salt having a solubility greater than 10mg / ml in pure water and an amount of solubilizing agent sufficient to produce in vivo a Cmax and / or an AUC that is greater by at least 10% that the Cmax and / or the AUC produced by a comparative composition of matter identical to the previous one but not including the said solubilizing agent.

ARP030102179A 1997-07-01 2003-06-19 COMPOSITIONS CONTAINING SERTRALINE SALT AR040279A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
AR040279A2 true AR040279A2 (en) 2005-03-23

Family

ID=21971159

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP980103146A AR015917A1 (en) 1997-07-01 1998-06-29 COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA
ARP030102180A AR040280A2 (en) 1997-07-01 2003-06-19 PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA
ARP030102179A AR040279A2 (en) 1997-07-01 2003-06-19 COMPOSITIONS CONTAINING SERTRALINE SALT

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ARP980103146A AR015917A1 (en) 1997-07-01 1998-06-29 COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA
ARP030102180A AR040280A2 (en) 1997-07-01 2003-06-19 PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA

Country Status (34)

Country Link
EP (1) EP0999829A1 (en)
JP (1) JP2000514100A (en)
KR (1) KR100366373B1 (en)
CN (1) CN1261794A (en)
AP (1) AP1192A (en)
AR (3) AR015917A1 (en)
AU (1) AU742535B2 (en)
BG (1) BG103918A (en)
BR (1) BR9810739A (en)
CA (1) CA2290974C (en)
CO (1) CO4940495A1 (en)
DZ (1) DZ2548A1 (en)
EA (1) EA002481B1 (en)
HN (1) HN1998000102A (en)
HR (1) HRP980377A2 (en)
HU (1) HUP0002236A3 (en)
ID (1) ID23429A (en)
IL (1) IL133076A (en)
IS (1) IS5260A (en)
MA (1) MA24587A1 (en)
NO (1) NO996520L (en)
OA (1) OA11243A (en)
PA (1) PA8454301A1 (en)
PE (1) PE97199A1 (en)
PL (1) PL337804A1 (en)
SK (1) SK181099A3 (en)
TN (1) TNSN98124A1 (en)
TR (1) TR199903297T2 (en)
TW (1) TW550087B (en)
UA (1) UA67741C2 (en)
UY (1) UY25071A1 (en)
WO (1) WO1999001120A1 (en)
YU (1) YU68299A (en)
ZA (1) ZA985708B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43702A (en) 1999-12-23 2004-11-25 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
AU2001276608A1 (en) 2000-08-30 2002-03-13 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
JP2010520897A (en) * 2007-03-12 2010-06-17 ディーエスエム アイピー アセッツ ビー．ブイ． Cosmetic composition
US20120289517A1 (en) * 2009-12-29 2012-11-15 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
CN102711763A (en) * 2009-12-29 2012-10-03 兴和株式会社 Pharmaceutical composition for oral administration
CN109908354A (en) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 Sertraline hydrochloride takes orally concentrate and its preparation process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0415612B1 (en) * 1989-08-30 1993-11-10 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
NO996520L (en) 2000-02-29
ZA985708B (en) 2000-01-10
SK181099A3 (en) 2000-07-11
WO1999001120A1 (en) 1999-01-14
AR015917A1 (en) 2001-05-30
TR199903297T2 (en) 2000-07-21
IS5260A (en) 1999-11-19
PL337804A1 (en) 2000-09-11
TNSN98124A1 (en) 2005-03-15
HRP980377A2 (en) 1999-04-30
KR20010013365A (en) 2001-02-26
UA67741C2 (en) 2004-07-15
AR040280A2 (en) 2005-03-23
CO4940495A1 (en) 2000-07-24
KR100366373B1 (en) 2003-01-14
OA11243A (en) 2003-07-24
HN1998000102A (en) 1999-01-08
CA2290974C (en) 2004-04-27
JP2000514100A (en) 2000-10-24
BG103918A (en) 2000-07-31
MA24587A1 (en) 1998-12-31
IL133076A (en) 2003-12-10
EA199900962A1 (en) 2000-08-28
HUP0002236A2 (en) 2003-08-28
TW550087B (en) 2003-09-01
AP1192A (en) 2003-07-23
HUP0002236A3 (en) 2003-12-29
UY25071A1 (en) 2000-12-29
EA002481B1 (en) 2002-06-27
YU68299A (en) 2002-06-19
AU742535B2 (en) 2002-01-03
IL133076A0 (en) 2001-03-19
PE97199A1 (en) 1999-10-05
EP0999829A1 (en) 2000-05-17
AP9801280A0 (en) 1998-06-30
AU7544898A (en) 1999-01-25
BR9810739A (en) 2000-09-12
ID23429A (en) 2000-04-20
PA8454301A1 (en) 2000-09-29
CA2290974A1 (en) 1999-01-14
NO996520D0 (en) 1999-12-28
DZ2548A1 (en) 2003-02-08
CN1261794A (en) 2000-08-02

Similar Documents

Publication Publication Date Title
CO4410315A1 (en) ORAL COMPOSITION INCLUDING EFFECTIVE AMOUNT OF SODIUM SURFACE AND SODIUM LAURYL SULFOACETATE
ES2167453T3 (en) MEDICINAL SUPPLY COMPOSITION CONTAINING CHITOSANE OR DERIVATIVE OF THE SAME WITH A POTENTIAL Z. DEFINED.
ATE80294T1 (en) INJECTABLE, OPACIFYING LIPOSOME COMPOSITION.
ES2176684T3 (en) NEW ASSOCIATIONS OF ACTIVE PRINCIPLES CONTAINING CLOPIDOGREL AND AN ANTHROMBOTIC.
ES2044156T3 (en) TRANSPARENT SOAP CONTAINING 1,2-ALCANODIOL.
PE68899A1 (en) COMPOSITION CONTAINING PARACETAMOL
AR040279A2 (en) COMPOSITIONS CONTAINING SERTRALINE SALT
ES2182255T3 (en) FLUORESCENT WHITENING AGENT.
MX9206150A (en) ANTI-INFLAMMATORY AGENTS OF TRIPEPTIDE DERIVATIVES
ES2103483T3 (en) LIQUID CLEANING COMPOSITIONS INCLUDING A PRIMARY ALKYL SULPHATE AND NON-IONIC SURFACTANTS.
ES2187489T3 (en) DICLOFENAC BASED PHARMACEUTICAL COMPOSITIONS.
MX169821B (en) CREAMY CLEANING COMPOCITIONS
ES2089613T3 (en) DETERGENT COMPOSITION.
GB9122674D0 (en) Toiletries composition
BR9810996A (en) Pharmaceutical composition
ES2066578T3 (en) CONCENTRATED LIQUID DETERGENT COMPOSITION CONTAINING A SEQUESTRATING AGENT OF THE POLYPHOSPHONATE TYPE.
KR960000200A (en) Oral Composition
AR007059A1 (en) USE OF INTERFERON IN THE PREPARATION OF MEDICINES AND COMPOSITIONS VIA OROMUCOSAL OR BY CONTACT
ES2139194T3 (en) PERFUME COMPOSITION.
ES2149736T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING STABLE AND ANTIOXIDANT FREE THENOPyrIDINE DERIVATIVES.
BR9808577A (en) Singlet oxygen generators having improved heavy atom effect.
MX169000B (en) WATER BASED CLEANING COMPOSITION
ATE82102T1 (en) DISINFECTANT.
MX168147B (en) SHAMPOO COMPOSITIONS
ES2162036T3 (en) ALKALINE DETERGENT WITH HIGH CONTENTS OF NON-IONIC TENSIANS AND COMPLEXING AGENT, AND USE OF AN ANOTHER COMPOUND AS A SOLUBIZER.

Legal Events

Date Code Title Description
FB Suspension of granting procedure